Claritas Pharmaceuticals (KALTF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 20 42 sessions, December 31, 2021 to March 15, 2022
- Largest daily move
- +58.3% close of March 2, 2022
Company Description
Claritas Pharmaceuticals (OTC: KALTF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $4.3M.
KALTF has declined 27.2% so far this year. The last closing price was $0.1100.
This page collects what Stock Titan holds for KALTF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Claritas Pharmaceuticals (KALTF) closed at $0.1100 on March 15, 2022. So far this year, the price has lost 27.2%.
KALTF Metrics & Rankings
Price returns through March 15, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Claritas Pharmaceuticals has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial, acquisition. View all KALTF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
KALTF Company Profile & Sector Positioning
Claritas Pharmaceuticals (KALTF) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing KALTF often look at related companies in the same sector, including Quoin Pharmaceuticals, Ltd. (QNRX), Jaguar Health, Inc. (JAGX), Azitra Inc (AZTR), CNS Pharmaceuticals, Inc. (CNSP), and XORTX Therapeutics Inc. (XRTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KALTF's relative position within its industry.